The aims of the 340B program are important. But, unfortunately, there is little evidence that the program is delivering on ...

Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash ...

Eli Lilly is taking the HRSA to court after the latter allegedly blocked the pharma's plan on the manner of offering ...

Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...

The case centers on the federal 340B program, in which drugmakers provide discounts to eligible healthcare providers that ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

Johnson & Johnson is escalating its fight with the federal government over its controversial plan to change how it doles out ...

Johnson & Johnson files suit against HHS over 340B program, proposing hospitals pay full price upfront for drugs and receive ...

It’s impossible to imagine that the creators of the program intended for billionaires to quality for 340B discounts.

Johnson and Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and ...